• Recursion CEO Chris Gibson on Accelerating the Biopharmaceutical Industry With AI - Ep. 230

  • Aug 7 2024
  • Length: 38 mins
  • Podcast

Recursion CEO Chris Gibson on Accelerating the Biopharmaceutical Industry With AI - Ep. 230

Listen for free

View show details

  • Summary

  • Techbio is a field combining data, technology and biology to enhance scientific processes — and AI has the potential to supercharge the biopharmaceutical industry further. In this episode of NVIDIA’s AI Podcast, host Noah Kravitz speaks with Chris Gibson, cofounder and CEO of Recursion, about how the company uses AI and machine learning to accelerate drug discovery and development at scale. Tune in to hear Gibson discuss how AI is transforming the biopharmaceutical industry by increasing efficiency and lowering discovery costs.
    Show More Show Less
Show More Show Less

What listeners say about Recursion CEO Chris Gibson on Accelerating the Biopharmaceutical Industry With AI - Ep. 230

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.